Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The EPIC Study: Exploring Paternal Age and the Influence on Blastocyst Culture

NCT: NCT06629766 · RECRUITING

NCT IDNCT06629766
StatusRECRUITING
Start Date2025-04-09
Completion2028-12
SponsorReproductive Medicine Associates of New Jersey (OTHER)
First posted
Last updated

Brief Summary

This study aims to assess the effect of age of the male partner and the reproductive ability of sperm prepared via sperm selection devices (Zymot) compared to routine embryologist selected sperm after density gradient centrifugation (DGC) preparation for intracytoplasmic sperm injection (ICSI) in patients undergoing in vitro fertilization treatment (IVF) of their infertility.

Frequently Asked Questions

What is The EPIC Study: Exploring Paternal Age and the Influence on Blastocyst Culture?

The EPIC Study: Exploring Paternal Age and the Influence on Blastocyst Culture is a clinical trial registered under NCT06629766. Current status: RECRUITING.

What is the status of NCT06629766?

The current status of NCT06629766 (The EPIC Study: Exploring Paternal Age and the Influence on Blastocyst Culture) is: RECRUITING.

When did The EPIC Study: Exploring Paternal Age and the Influence on Blastocyst Culture start?

The EPIC Study: Exploring Paternal Age and the Influence on Blastocyst Culture started on 2025-04-09.

Related Devices

K153290Sydney IVF Follicle Flush Buffer, Sydney IVF Fertilization Medium, Sydney IVF Cleavage Medium, Sydney IVF Blastocyst MediumWilliam A. Cook Australia Pty. , Ltd. K173075ZyMot ICSI Sperm Separation Device, ZyMot Multi Sperm Separation Device (850µl, 3ml)Dxnow, Inc. K200249Sequential Culture Media (Fertilization Medium [without HSA/rHA, with HSA, with rHA], Cleavage Medium [without HSA/rHA, with HSA, with rHA], Blastocyst Medium [without HSA/rHA, with HSA, with rHA])Kitazato Corporation

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑